REDUCING THE RISK OF VIRUS TRANSMISSION BY BLOOD PRODUCTS
- 1 December 1988
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 70 (4) , 393-395
- https://doi.org/10.1111/j.1365-2141.1988.tb02506.x
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- VIRUS SAFETY OF SOLVENT/DETERGENT-TREATED ANTIHAEMOPHILIC FACTOR CONCENTRATEThe Lancet, 1988
- Post-Transfusion Non-A, Non-B Hepatitis: Significance of Raised ALT and Anti-HBc in Blood DonorsVox Sanguinis, 1988
- HTLV‐ 1 and blood transfusionTransfusion, 1988
- HIV Antibody Screening of Blood Donations in the United KingdomVox Sanguinis, 1988
- Transfusion-Associated Hepatitis and AIDSNew England Journal of Medicine, 1987
- Absence of Hepatitis after Treatment with a Pasteurized Factor VIII Concentrate in Patients with Hemophilia and No Previous TransfusionsNew England Journal of Medicine, 1987
- Inactivation and partition of human T‐cell lymphotrophic virus, type III, during ethanol fractionation of plasmaTransfusion, 1986
- STERILISATION OF HEPATITIS AND HTLV-III VIRUSES BY EXPOSURE TO TRI(n-BUTYL)PHOSPHATE AND SODIUM CHOLATEThe Lancet, 1986
- Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell AnemiaScience, 1985
- CASE FOR CONCLUDING THAT HEAT-TREATED, LICENSED ANTI-HAEMOPHILIC FACTOR IS FREE FROM HTLV-IIIThe Lancet, 1985